Skip to content
LIVE MARKETS
--:--:--
ET
Testsite
Thoughts, stories and ideas.
40 filings/day — zero noise
Today's
stories · chronological wire
Search the wire
⌘K
Sign in
Subscribe
Home
ROIV
ROIV
1 story on the wire
ROIV
1 filing
Chronological · ET
15:53
ROIV
FDA Approves Lisraya, First Oral Drug for Dermatomyositis in Adults
The FDA has cleared Lisraya (brepocitinib) tablets, the first oral therapy specifically indicated for adults with dermatomyositis.
Regulatory
Sep 2
10 days ago
PRO
No filings match.
Try another ticker or clear the filter.
LOAD EARLIER